Loop diuretics and angiotensin-converting enzyme inhibitors increased risk for hospitalization for lithium toxicity
- COMMENTARY: Loop diuretics and angiotensin-converting enzyme inhibitors increased risk for hospitalization for lithium toxicity. Laville, Maurice // ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p25
The article reports that loop diuretics and angiotensin-converting enzyme inhibitors increased risk for hospitalization for lithium toxicity. Older patients with decreased glomerular filtration rate are at risk for renal insufficiency after diuretic-induced volume contraction, and it is likely...
- Nephrotic Syndrome in Adults: Diagnosis and Management. KODNER, CHARLES // American Family Physician;11/15/2009, Vol. 80 Issue 10, p1129
Nephrotic syndrome may be caused by primary (idiopathic) renal disease or by a variety of secondary causes. Patients present with marked edema, proteinuria, hypoalbuminemia, and often hyperlipidemia. In adults, diabetes mellitus is the most common secondary cause, and focal segmental...
- SHOULD ANGIOTENSIN CONVERTING ENZYME INHIBITORS BE USED IN CHILDREN WITH TYPE 1 DIABETES AND MICROALBUMINURIA? Almerie, M. Q.; Williams, R. M.; Acerini, C. L. // Archives of Disease in Childhood;Jul2008, Vol. 93 Issue 7, p633
The article provides an answer to the question on whether angiotensin converting enzyme inhibitors should be used in children with type 1 diabetes and microalbuminuria.
- Atrial Fibrillation after radiorequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics. Anné, W.; Willems, R.; van der Merwe, N.; van der Werf, F.; Ector, H.; Heibüchel, H. // Heart;Sep2004, Vol. 90 Issue 9, p1025
Objectives: To determine risk factors for the development of atrial fibrillation (AF) alter atrial flutter (AR) ablation; and to study the relation between AF development and periprocedural drug use. Methods: AFL ablation was performed in 196 patients. The relation between AF occurrence and...
- Hypertension. // Heart;May2003, Vol. 89 Issue 5, p583
Cites the result of a study pertaining to the control of hypertension. Comparison between angiotensin-converting enzyme (ACE) inhibitors and diuretics; Additional benefits of ACE inhibitors.
- Chronic heart failure: Survival higher with ACE II blocker versus traditional therapy. // Geriatrics;May97, Vol. 52 Issue 5, p82
Evaluates the effectiveness of Losartan potassium (Cozaar), an angiotensin receptor antagonist against traditional therapy for the treatment of older patients with heart failure. The Evaluation of Losartan in the Elderly study; Findings of the study; Notion of Bertram Pitt, professor and...
- Therapeutic Options for the Management of the Cardiorenal Syndrome. Koniari, Katerina; Nikolaou, Marinos; Paraskevaidis, Ioannis; Parissis, John // International Journal of Nephrology;2011, p1
Patients with heart failure often present with impaired renal function, which is a predictor of poor outcome. The cardiorenal syndrome is the worsening of renal function, which is accelerated by worsening of heart failure or acute decompensated heart failure. Although it is a frequent clinical...
- Modern drug treatment of chronic asthma. Lipworth, Brian J // BMJ: British Medical Journal (International Edition);02/06/99, Vol. 318 Issue 7180, p380
Provides a brief overview of modern drug treatment for chronic asthma. Corticosteroids; Cromones; Leukotriene antagonists.
- Heart failure with preserved ejection fraction. Pellicori, Pierpaolo; Cleland, John GF // Clinical Medicine;2014 Supplement, Vol. 14, ps22
Many patients with heart failure (HF) have a normal left ventricular ejection fraction, and are labelled as having HF with preserved left ventricular ejection fraction (HFPEF). Hypertension, atrial fibrillation and age are important contributors to the development of HFPEF and, therefore, its...